on 22 Mar 2022
Last Applicant/ Owned by
Cronenburg 75
AMSTERDAM
NL
1081GM
Serial Number
90133236 filed on 24th Aug 2020
Registration Number
6674974 registered on 22nd Mar 2022
Correspondent Address
Roberta S. Bren
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugsRead More
Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations
Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products
No 90133236
No Service Mark
No KILB.00046.T
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 22nd Mar 2022 | REGISTERED-PRINCIPAL REGISTER |
| 11th Feb 2022 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 11th Feb 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Jan 2022 | NOTICE OF ALLOWANCE CANCELLED |
| 18th Jan 2022 | TEAS DELETE 1(B) BASIS RECEIVED |
| 19th Oct 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Aug 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Aug 2021 | PUBLISHED FOR OPPOSITION |
| 04th Aug 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 20th Jul 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
